Taken together, CD147 overexpression significantly worsened pathological cardiac hypertrophy compared with the vehicle group, and the glycosylation-defective CD147 abrogated these detrimental effects when compared with wild-type CD147 overexpression. The gene discussed is BSG; the disease is cardiac hypertrophy.